INNOVENTIV IP

Innoventiv IP:

• Evaluates and advises upper management on chemical/biological/device/diagnostic IP portfolios, IP management/strategy, transactions, generic competition strategy, FDA/Hatch-Waxman regulations and IP litigation support
• Provides freedom-to-operate, patentability, patent validity, infringement, inventorship and ownership evaluations
• Designs and implements creative strategies to identify new patents/regulatory exclusivities and maximize IP value
• Drafts and negotiates agreements (licensing, M&A, collaborations, development, services, manufacturing/supply, CDA, MTA and clinical trial agreements)
• Conducts IP due diligence
• Manages outside counsel to reduce legal and IP costs
• Serves as part-time, in-house General and Intellectual Property Counsel
• Presents IP positions and strategies to company boards and potential investors
• Serves as expert witness for pharmaceutical/chemical patent litigation

Through a separate consulting company, Pharmidable Legal Advisors, LLC, Bob and colleague Randy Zakreski, Esq. provide further creative, cutting-edge pharma/bio/device/diagnostic related life-cycle-management services to significantly increase IP and regulatory exclusivity value.

Bob and Randy recently conducted a llfe-cycle management project and identified a creative strategy to obtain several years of Patent Term Extension for a key combination drug-device product.

For more Information about Pharmidable's services, please visit www.pharmidablelegal.com



Please note that prior results do not predict, warrant or guarantee a similar outcome, since results will vary depending on the facts and circumstances of each individual matter.